Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1-Reference-Cited by-同舟云学术

Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1

Published:2013-04-12 Issue:6 Volume:85 Page:1028-1036
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Akuta Norio,Suzuki Fumitaka,Seko Yuya,Kawamura Yusuke,Sezaki Hitomi,Suzuki Yoshiyuki,Hosaka Tetsuya,Kobayashi Masahiro,Hara Tasuku,Kobayashi Mariko,Saitoh Satoshi,Arase Yasuji,Ikeda Kenji,Kumada Hiromitsu

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.23579/fullpdf

Reference37 articles.

1. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype1b high viral load and non-virological response to interferon-ribavirin combination therapy;Akuta;Intervirology,2005

2. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis;Akuta;Hepatology,2007

3. Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin;Akuta;Hepatology,2010

4. Determinants of response to triple therapy of telaprevir, peginterferon, and ribavirin in previous non-responders infected with HCV genotype 1;Akuta;J Med Virol,2012a

5. Complicated relationships of amino acid substitution in HCV core region and IL28B genotype influencing hepatocarcinogenesis;Akuta;Hepatology,2012b

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Simple but Accurate Method for Evaluating Drug-Resistance in Infectious HCVcc System;BioMed Research International;2017

2. Resistance-Associated Variants in the NS5A Region of HCV and Methods for the Detection;Hepatitis C Virus Treatment;2016-11-02

3. Treatment of Chronic Hepatitis C with the First-Generation Protease Inhibitor Telaprevir: Its Efficacy and Resistance Mutations;Hepatitis C Virus Treatment;2016-11-02

4. Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection;Hepatology Research;2016-10-26

5. Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients;International Journal of Molecular Sciences;2016-08-27